EWP
TEVA icon

Elevation Wealth Partners’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Elevation Wealth Partners’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.35K Hold
135
– – ﹤0.01% 1087
2026
Q2 		$4.57K Buy
+135
New +$4.5K ﹤0.01% 1040

Other funds holding TEVA

WWM
Whalen Wealth Management Las Vegas, Nevada $234M AUM 28.06% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
CAM
Cacti Asset Management Atlanta, Georgia $1.89B AUM 58.55% 1-Year Est. Return
IRC
Investors Research Corp Atlanta, Georgia $569M AUM 15.41% 1-Year Est. Return
VEM
Vann Equity Management Plano, Texas $168M AUM
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return
BAM
Byrne Asset Management Kingston, New Jersey $179M AUM 29.67% 1-Year Est. Return
AAG
Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return

Elevation Wealth Partners's TEVA Position: Q3 2026 in Review

Elevation Wealth Partners held its Teva Pharmaceutical Industries Limited (TEVA) position steady in Q3 2026 at 135 shares worth $5.35K. The position accounts for ﹤0.01% of the portfolio, ranked #1087.

Elevation Wealth Partners first reported a position in TEVA in Q2 2026 and has held it in 2 quarters since. 10 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.

  • Elevation Wealth Partners held 135 shares of Teva Pharmaceutical Industries Limited worth $5.35K as of Q3 2026.
  • Elevation Wealth Partners left its Teva Pharmaceutical Industries Limited share count unchanged in Q3 2026.
  • Teva Pharmaceutical Industries Limited made up ﹤0.01% of Elevation Wealth Partners's portfolio in Q3 2026, its #1087 holding.
  • Elevation Wealth Partners first reported a position in Teva Pharmaceutical Industries Limited in Q2 2026 and has held it in 2 quarters since.
  • 10 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2026.

Based on Elevation Wealth Partners's 13F filing for Q3 2026, filed 7 Oct 2026.